In one lung study, 12/183 (7%) adenocarcinoma specimens had RBM10 mutations, each patient having a different mutation (5/12 being missense, 5/12 truncating and 2/12 splice-site) [10]. This evidence concerns the gene RBM10 and adenocarcinoma.